Related Experiment Video
Updated: Mar 24, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Autologous stem cell transplant for severe, progressive juvenile systemic sclerosis
Shaikha Alqahtani1, Fabiana Cacace1,2, Andrea Bauchat1
1Pediatric Transplant and Cellular Therapy, Duke University, Durham, NC 27705, United States.
None:
Juvenile systemic sclerosis (jSSc) is a rare, chronic, autoimmune disease in children/adolescents and is associated with significant morbidity, skin thickening/hardening (scleroderma), organ toxicity and sub-optimal therapeutic options. In this report, autologous stem cell transplantation is associated with clinical improvement in a 17-year-old with refractory jSSc.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
iPS Cell Differentiation
Adult Stem Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Mesenchymal Stem Cells

